ASP Isotopes Inc. Common Stock (ASPI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
ASP Isotopes Inc. Common Stock stock (ASPI) is currently trading at $4.98. ASP Isotopes Inc. Common Stock PS ratio (Price-to-Sales) is 62.90. Analyst consensus price target for ASPI is $12.00. WallStSmart rates ASPI as Sell.
- ASPI PE ratio analysis and historical PE chart
- ASPI PS ratio (Price-to-Sales) history and trend
- ASPI intrinsic value — DCF, Graham Number, EPV models
- ASPI stock price prediction 2025 2026 2027 2028 2029 2030
- ASPI fair value vs current price
- ASPI insider transactions and insider buying
- Is ASPI undervalued or overvalued?
- ASP Isotopes Inc. Common Stock financial analysis — revenue, earnings, cash flow
- ASPI Piotroski F-Score and Altman Z-Score
- ASPI analyst price target and Smart Rating
ASP Isotopes Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
ASP Isotopes Inc. Common Stock (ASPI) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth, institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
ASP Isotopes Inc. Common Stock (ASPI) Key Strengths (2)
Revenue surging 349.50% year-over-year
53.09% held by institutions, strong professional interest
Supporting Valuation Data
ASP Isotopes Inc. Common Stock (ASPI) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Very expensive at 62.9x annual revenue
Very expensive at 7.1x book value
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
ASP Isotopes Inc. Common Stock (ASPI) Detailed Analysis Report
Overall Assessment
This company scores 25/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth, Institutional Own.. Growth metrics are encouraging with Revenue Growth at 349.50%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (62.90), Price/Book (7.13) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -152.60%, Operating Margin at -306.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -152.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 349.50% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ASPI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ASPI's Price-to-Sales ratio of 62.90x trades at a deep discount to its historical average of 361.44x (30th percentile). The current valuation is 96% below its historical high of 1603.51x set in Nov 2024, and 3356% above its historical low of 1.82x in May 2023. Over the past 12 months, the PS ratio has compressed from ~126.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for ASP Isotopes Inc. Common Stock (ASPI) · BASIC MATERIALS › CHEMICALS
The Big Picture
ASP Isotopes Inc. Common Stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 8M with 350% growth year-over-year.
Key Findings
Revenue growing at 350% YoY, reaching 8M. This pace significantly outperforms most CHEMICALS peers.
Spending 37% of revenue (3M) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -12M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can ASP Isotopes Inc. Common Stock maintain 350%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 3.57, so expect amplified moves relative to the broader market.
Sector dynamics: monitor CHEMICALS industry trends, competitive moves, and regulatory changes that could impact ASP Isotopes Inc. Common Stock.
Bottom Line
ASP Isotopes Inc. Common Stock is a high-conviction growth story with revenue accelerating at 350% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(0 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 10:00:56 AM
About ASP Isotopes Inc. Common Stock(ASPI)
NASDAQ
BASIC MATERIALS
CHEMICALS
USA
Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.